Page 15 - Jay Flatley News Today : Breaking News, Live Updates & Top Stories | Vimarsana

By Ari Levy, CNBC • Updated on August 3, 2021 at 8:15 pm Mark Neuling | CNBC Zymergen went public at $31 a share in April and traded as high as $48.50, valuing the company at $4.8 billion. The stock sank to $11.07 after hours on Tuesday, leaving its market cap at just over $1 billion. The company has yet to start generating product sales and said it now expects revenue from its products to be "immaterial" through 2022. A little more than three months after pricing its IPO at the top of its expected range and soaring out of the gate, Zymergen is warning investors that revenue fro...

More Than a Threat: China Collects Americans’ DNA Commentary In the past few years, the United States has come to the realization and consensus that China, with its ambition to achieve global domination and its complete disregard for ethics and humanity, has become the number one threat to the United States and the rest of the free world. Espionage by China has long been a known threat, and each day the world learns a little bit more about the extensive reach of China’s information theft in many territories. The most recent discovery is that China has been openly and discreetly collecting...

Industry Pioneer Jay Flatley Named as Chairman of Zymergen Board of Directors Brings decades of leadership in high-growth biotechnology and sciences companies News provided by Share this article Jay Flatley as the Chairman of the Board of Directors, effective immediately. Jay has served as lead Independent Director on Zymergen's board since late 2019. "Over the last 8 years, we've built a powerful biofacturing platform and excellent customer relationships in our key verticals," said Zymergen CEO, Josh Hoffman. "As we mature as a company, we are strengthening our Board and governance practices...

Advertisement Britain's top mandarin has warned high-level Whitehall officials should not have second jobs because it threatens the 'integrity and impartiality' of the civil service as he ordered a crackdown on mandarins with 'problematic' external paid roles amid the David Cameron lobbying scandal. Cabinet Secretary Simon Case, formerly private secretary to the Duke of Cambridge, yesterday ordered the heads of all government departments to search their ranks for civil servants taking money for a second job that could pose a potential conflict of interest. In a letter sent to senior mandarins...

Bill Crothers was Government procurement head while a Greensill board adviser When he quit to work for the lender full-time he did not have to ask for approval He later received shares that could have been worth more than £5million   It comes as the lobbying scandal around David Cameron continues to grow  A photo of the former PM's trip to Saudi Arabia with Lex Greensill was released